SinoMab BioScienceの売上総利益
SinoMab BioScienceの売上総利益 は何ですか。
SinoMab BioScience Limitedの売上総利益 は78.59%です。
売上総利益 の定義は何ですか。
売上総利益は、売上と商品の売上原価との差を収益で除してパーセンテージで表したものです。
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
HKSEのセクタHealth Careにおける売上総利益 の企業と比べるSinoMab BioScience
SinoMab BioScienceは何をしますか。
SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases, primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA), as well as in various clinical stages for other immunological diseases, such as systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), and non-Hodgkin's lymphoma (NHL). The company also focuses on developing SN1011, a Bruton's tyrosine kinase inhibitor, which is Phase I clinical trial for the treatment of RA, SLE, pemphigus, multiple sclerosis, and other immunological diseases. Its products under preclinical stage comprise SM17 for the treatment of asthma and idiopathic pulmonary fibrosis; SM09 that is used for the treatment of NHL and RA; SM06 for use in treating RA, SLE, and SS; and TNF2 for the treatment of RA. The company operates in Mainland China, the Cayman Islands, and Hong Kong. SinoMab BioScience Limited was incorporated in 2001 and is headquartered in Pak Shek Kok, Hong Kong.
SinoMab BioScienceと類似の売上総利益
- Rua Life Sciences Plcの売上総利益 は78.54%です。
- Acrow Formwork and Construction Servicesの売上総利益 は78.56%です。
- Unitiの売上総利益 は78.57%です。
- LifeTech Scientificの売上総利益 は78.57%です。
- Servicenow Dl ,001の売上総利益 は78.59%です。
- ServiceNow Incの売上総利益 は78.59%です。
- SinoMab BioScienceの売上総利益 は78.59%です。
- Tera Softwareの売上総利益 は78.59%です。
- i-nexus Global plcの売上総利益 は78.59%です。
- F-Secure Oyjの売上総利益 は78.60%です。
- Magellanの売上総利益 は78.61%です。
- Prozone Intu Propertiesの売上総利益 は78.63%です。
- Pandora ASの売上総利益 は78.63%です。